GT
NXTM

Glenmede Trust’s NxStage Medical Inc. NXTM Stock Holding History

Glenmede Trust’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-145
Closed -$4 – 3260
2018
Q4 		$4 Buy
+145
New +$4.12K ﹤0.01% 2632
2017
Q4 		– Sell
-1
Closed – – 2878
2017
Q3 		$0 Sell
1
-39
-98% -$1.04K ﹤0.01% 2914
2017
Q2 		$1K Hold
40
– – ﹤0.01% 2629
2017
Q1 		$1K Hold
40
– – ﹤0.01% 2629
2016
Q4 		$1K Buy
40
+39
+3,900% +$965 ﹤0.01% 2437
2016
Q3 		$0 Hold
1
– – ﹤0.01% 2728
2016
Q2 		$0 Sell
1
-165
-99% -$2.94K ﹤0.01% 2793
2016
Q1 		$2K Buy
166
+78
+89% +$1.31K ﹤0.01% 2435
2015
Q4 		$1K Hold
88
– – ﹤0.01% 2600
2015
Q3 		$1K Sell
88
-6
-6% -$96 ﹤0.01% 2654
2015
Q2 		$1K Buy
+94
New +$1.59K ﹤0.01% 2611

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Glenmede Trust's NXTM Position: Q1 2019 in Review

Glenmede Trust sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 145 shares — an estimated $4 sold.

Glenmede Trust first reported a position in NXTM in Q2 2015 and held it in 11 quarters. The position peaked at $2K in Q1 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Glenmede Trust reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Glenmede Trust sold 145 NxStage Medical Inc. shares in Q1 2019, an estimated $4.
  • Glenmede Trust first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 11 quarters.
  • Glenmede Trust's NxStage Medical Inc. position peaked at $2K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Glenmede Trust's 13F filing for Q1 2019, filed 14 May 2019.